# Capra Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/capra-biosciences

- Industry: Industrial Machinery
- Headquarters: Manassas, US
- Website: www.caprabiosciences.com
- Latest round: Seed (Nov 13, 2020)
- Investors on record: 2

## About

Capra Biosciences Inc. is a company focused on producing renewable chemicals using innovative bioreactor technology, offering high-performance products such as retinol and hydrophobic lubricants, contributing to sustainable chemical solutions.Founded in 2020 by Andrew Magyar, Capra Biosciences Inc. is headquartered in Manassas, US. The company specializes in the production of renewable chemicals through advanced bioreactors. It has completed 5 deals as of June 6, 2022, when it raised USD 1.8 mn in funding from investors including Decarbonization Consortium and E14 Fund, bringing the total capital raised to USD 3.4 mn.Capra Biosciences specializes in the production of high-performance renewable chemicals through its innovative bioreactor technology. The company's primary offerings include retinol, a form of vitamin A used in anti-aging cosmetics, and various hydrophobic lubricants. These products are manufactured using biological processes that convert waste materials into valuable chemicals, aligning with sustainable practices. The bioreactors employed by Capra utilize biofilms to facilitate the biosynthesis of these chemicals. Capra's products target industries focused on cosmetics and personal care, with an emphasis on providing environmentally friendly alternatives.Capra Biosciences generates revenue through direct sales of its chemical products to businesses within the cosmetics and personal care industries. The company engages in B2B transactions, supplying retinol and lubricants to manufacturers who incorporate these materials into their product lines. Partnerships with retailers and wholesalers further facilitate distribution, enhancing product availability in the market. The pricing structure for Capra's offerings reflects their sustainable chemicals' premium nature, catering to clients seeking eco-friendly solutions.In June 2022, Capra Biosciences Inc. raised USD 1.8 mn in pre-seed funding, which will be utilized to build its production-scale reactor and enhance its capabilities to include lubricants. The company aims to expand into North America and Europe by developing new products designed for these markets. Specific timelines for new product launches and market entry are to be determined as the company leverages its recent funding.

## Funding rounds

- Seed, Nov 13, 2020 — SOSV, IndieBio

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed